4//SEC Filing
Ellis Ronald J. Jr. 4
Accession 0001192482-19-000432
CIK 0001561921other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 9:06 PM ET
Size
9.0 KB
Accession
0001192482-19-000432
Insider Transaction Report
Form 4
TELA Bio, Inc.TELA
Ellis Ronald J. Jr.
Director10% Owner
Transactions
- Conversion
Series B Preferred Stock
2019-11-13−14,329,052→ 0 total(indirect: By IRA)→ Common Stock (580,357 underlying) - Conversion
Common Stock
2019-11-13+580,357→ 774,056 total(indirect: By IRA)
Pacira BioSciences, Inc.
10% Owner
Transactions
- Conversion
Series B Preferred Stock
2019-11-13−14,329,052→ 0 total(indirect: By IRA)→ Common Stock (580,357 underlying) - Conversion
Common Stock
2019-11-13+580,357→ 774,056 total(indirect: By IRA)
Footnotes (3)
- [F1]Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.
- [F2]Reflects 193,699 shares of common stock received as a payment-in-kind dividend on Series B Preferred Stock exempt from reporting under Rule 16a-9(a).
- [F3]Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.
Documents
Issuer
TELA Bio, Inc.
CIK 0001561921
Entity typeother
Related Parties
1- filerCIK 0001790670
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 9:06 PM ET
- Size
- 9.0 KB